Week29, 2023
1. Influenza activity remains minimal nationwide, with 1.0% of clinical specimens testing positive for influenza during Week 29.
2. Of 225 positive clinical specimens, 63.1% were Influenza A and 36.9% were Influenza B.
3. Public health labs detected 39 positive specimens, with 74.4% Influenza A (85.7% H1N1 and 14.3% H3N2) and 25.6% Influenza B (all Victoria lineage).
4. Nationwide outpatient visits for influenza-like illness (ILI) accounted for 1.1%, similar to recent weeks and below the national baseline.
5. Hospitalizations for laboratory-confirmed influenza totaled 573 in Week 29.
6. Deaths from pneumonia, influenza, or COVID-19 (PIC) constituted 5.6% of all deaths, meeting the epidemic threshold.
7. One pediatric influenza-associated death was reported this season, bringing the total to 164.
8. Multiple respiratory viruses continue to co-circulate, contributing to ILI cases, including influenza, SARS-CoV-2, and RSV.
9. No new trends in vaccination data were reported, with continued emphasis on annual flu vaccination.
10. CDC anticipates low flu activity but highlights variability by region and co-circulating pathogens that may influence future trends.